These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17804962)

  • 21. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
    J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S; Guzick D
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of polycystic ovary syndrome with cardiovascular risk factors.
    Akram T; Hasan S; Imran M; Karim A; Arslan M
    Gynecol Endocrinol; 2010 Jan; 26(1):47-53. PubMed ID: 19639500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A; Yetkin G
    Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome.
    Pandolfi C; Zugaro A; Lattanzio F; Necozione S; Barbonetti A; Colangeli MS; Francavilla S; Francavilla F
    Metabolism; 2008 Jul; 57(7):999-1004. PubMed ID: 18555843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of insulin in polycystic ovary syndrome].
    Sindelka G; Skrha J; Cibula D; Prázný M
    Cas Lek Cesk; 2002 Dec; 141(24):769-72. PubMed ID: 12661468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
    Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome].
    Qu ZY; Shi YH; Zhao DN; Jiang JJ; Ma ZX; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2036-9. PubMed ID: 21029639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polycystic ovary syndrome: the importance of establishing diagnosis].
    Sir-Petermann T; Maliqueo M; Pérez-Bravo F; Angel B; Carvajal F; del Solar MP; Benítez R
    Rev Med Chil; 2001 Jul; 129(7):805-12. PubMed ID: 11552451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST; Nestler JE
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance.
    Moran LJ; Noakes M; Clifton PM; Norman RJ; Fenech MF
    Mutat Res; 2008 Mar; 639(1-2):55-63. PubMed ID: 18178226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abdominal adiposity and the polycystic ovary syndrome.
    Escobar-Morreale HF; San Millán JL
    Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body iron stores and gender differences in risk factors for coronary heart disease.
    Mascitelli L; Pezzetta F; Goldstein MR
    Maturitas; 2010 May; 66(1):107. PubMed ID: 20185255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.